CompletedNCT03775109
Blocking IL-1 Signals in Alcohol-Related Hepatitis
About this title
Read the official source — NCT03775109Medication studyAges 18+United KingdomAddiction
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Bristol and 15 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: February 12, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 55
- Sponsor
- Imperial College London
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United Kingdom
- Age range
- Over 18 Years
- Official registry ID
- NCT03775109
- Official title
Show the full official title
IL-1 Signal Inhibition in Alcoholic Hepatitis (ISAIAH)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bristol · Glasgow · Leeds
7 more locations
- Liverpool
- London
- Newcastle upon Tyne
- Nottingham
- Oxford
- Plymouth
- Southampton
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Imperial College London, a university.
Did this study involve medication?
Yes. The study involved medication, including Canakinumab 150mg/ml solution for injection and Placebo.
Who was this study for?
Listed age limits: from 18 years.
